clinical-stage drug development companies
Companies whose enriched business profile is tagged “clinical-stage drug development”, drawn from their SEC filings + website text. Sorted by market capitalization; every figure is delayed data from SEC EDGAR + Finnhub, shown with its as-of date.
- COGENT BIOSCIENCES INC (COGT) Health Care — Early-stage biotech company developing tyrosine kinase inhibitors for oncology with bezuclastinib as its lead clinical-stage candidate. ask →
- DIANTHUS THERAPEUTICS INC (DNTH) Health Care — A clinical-stage therapeutics company developing novel small-molecule drug candidates for undisclosed therapeutic indications. ask →
- ENLIVEN THERAPEUTICS INC (ELVN) Health Care — An early-stage biotech advancing ELVN-001, a novel BCR-ABL inhibitor, through clinical trials for chronic myeloid leukemia and related blood cancers. ask →
- RECURSION PHARMACEUTICALS INC CLAS (RXRX) Health Care — Recursion is a clinical-stage AI-native drug discovery platform that uses machine learning and biological datasets to rapidly identify and develop novel medicines. ask →
- ACHIEVE LIFE SCIENCES INC (ACHV) Health Care — A clinical-stage biotech developing cytisinicline for smoking cessation and nicotine dependence, preparing for commercialization after completing key clinical trials. ask →
- ASSEMBLY BIOSCIENCES INC (ASMB) Health Care — Assembly Biosciences develops next-generation antivirals targeting herpes and hepatitis viruses, with a portfolio advancing through clinical trials and now powered by a Gilead partnership licensing its genital herpes program. ask →
- PRELUDE THERAPEUTICS INC (PRLD) Health Care — An early-stage biopharma company developing novel small-molecule drug candidates targeting protein-driven disease mechanisms. ask →
- INHIBIKASE THERAPEUTICS INC (IKT) Health Care — A pre-revenue biotech company developing IKT-001, a novel therapeutic targeting pulmonary arterial hypertension, currently in Phase 3 clinical trials with no approved products or operating revenue. ask →
Not quite it? Describe exactly what you want →
Data: SEC EDGAR (filings) + Finnhub (fundamentals, delayed daily-close). Figures shown with their as-of date.
Last updated 2026-07-10.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.